Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

CRScube Expands Global Presence with New Office in the UK
  • USA - English


News provided by

CRScube Inc.

01 Aug, 2024, 17:30 IST

Share this article

Share toX

Share this article

Share toX

LONDON, Aug. 1, 2024 /PRNewswire/ -- CRScube Inc. (CEO Stanley Kim), a leading clinical trial software solutions company, proudly announces the opening of its new office in London, marking a significant milestone in its global expansion strategy. Building on a foundation of unparalleled success in Asia, this strategic move underscores the company's commitment to bringing innovative solutions to the European and US markets.

CRScube's solutions have been utilized in over 5,000 clinical trials internationally over the past 14 years. It is the leader in Electronic Data Capture (EDC) solution in Korea, and it has established a robust presence across Asia. The company's relentless dedication to excellence and innovation has not only solidified its reputation but also driven significant growth, making it a trusted name in the Clinical Trials industry.

"We are thrilled to expand our footprint into the UK," said Stanley Kim, CEO of CRScube. "Our success in Asia has laid a strong foundation, and we are excited to bring our innovative solutions to sponsors and CROs in Europe and the US."

To boost its global competitiveness, CRScube recently recruited two seasoned professionals, Juan Munoz-Pujol, Chief Strategy & Development Officer (CSDO), and Sylvain Berthelot, VP of Strategy and Marketing. "Our London office is a critical step in our international growth strategy," added Juan Munoz-Pujol, CSDO. "This expansion allows us to better serve our clients in Europe and the US, providing localized support while leveraging our global expertise."

With offices in Japan, Korea, China, Europe and the United States, CRScube continues developing its global vision: driving innovation and delivering exceptional value to the Clinical Trials industry worldwide.

About CRScube

CRScube is on a mission to make clinical trials accessible to everyone. We provide a cloud-native eClinical platform that is easy to build and easy to use, increasing efficiency during both study start-up and execution. We are passionate about making clinical trials more affordable to run, without missing out on innovation.

Website: https://www.crscube.io/

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.